D. Schuppan, N. H. Afdhal, Liver cirrhosis, Lancet 371 (2008) 838–851.
 D. Moradpour, H. E. Blum, Pathogenesis of hepatocellular carcinoma, European Journal Of Gastroenterology & Hepatology 17 (2005) 477–483.
 A. Arzumanyan, H. M. G. P. V. Reis, M. A. Feitelson, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma, Nature Reviews Cancer 13 (2013) 123–135.
 Y. Shokoohinia, M. Rashidi, L. Hosseinzadeh, Z. Jelodarian, Quercetin–3-O-beta-D-glucopyranoside, a dietary flavonoid, protects PC12 cells from H2O2-induced cytotoxicity through inhibition of reactive oxygen species, Food Chemistry 167 (2015) 162–167.
 H. Sonoki, T. Sato, S. Endo, T. Matsunaga, M. Yamaguchi, Y. Yamazaki, J. Sugatani, A. Ikari, Quercetin Decreases Claudin–2 Expression Mediated by Up-Regulation of microRNA miR–16 in Lung Adenocarcinoma A549 Cells, Nutrients 7 (2015) 4578–4592.
 M. Pinelo, L. Manzocco, M. J. Nunez, M. C. Nicoli, Solvent effect on quercetin antioxidant capacity, Food Chemistry 88 (2004) 201–207.
 T. Hatahet, M. Morille, A. Shamseddin, A. Aubert-Pouessel, J. M. Devoisselle, S. Begu, Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide, International Journal Of Pharmaceutics 518 (2017) 167–176.
 M. K. Kemelo, A. Pierzynova, N. K. Canova, T. Kucera, H. Farghali, The involvement of sirtuin 1 and heme oxygenase 1 in the hepatoprotective effects of quercetin against carbon tetrachloride-induced sub-chronic liver toxicity in rats, Chemico-Biological Interactions 269 (2017) 1–8.
 A. Ghosh, A. K. Mandal, S. Sarkar, N. Das, Hepatoprotective and neuroprotective activity of liposomal quercetin in combating chronic arsenic induced oxidative damage in liver and brain of rats, Drug Delivery 18 (2011) 451–459.
 L. L. Ji, Y. C. Sheng, Z. Y. Zheng, L. Shi, Z. T. Wang, The involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity, Free Radical Biology And Medicine 85 (2015) 12–23.
 I. M. Afifi NA, Galal M, Hepato-protective influence of quercetin and ellagic acid on thioacetamide-induced hepatotoxicity in rats, Can J Physiol Pharmacol 10.1139/cjpp–2017–0651 (2018).
 H. Zhuo, B. Zheng, J. Liu, Y. Huang, H. Wang, D. Zheng, N. Mao, J. Meng, S. Zhou, L. Zhong, Y. Zhao, Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes, J Exp Clin Cancer Res 37 (2018) 42.
 G. Wang, J. J. Wang, G. Y. Yang, S. M. Du, N. Zeng, D. S. Li, R. M. Li, J. Y. Chen, J. B. Feng, S. H. Yuan, F. Ye, Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death, International Journal Of Nanomedicine 7 (2012) 271–280.
 P. Mukhopadhyay, S. Maity, S. Mandal, A. S. Chakraborti, A. K. Prajapatia, P. P. Kundu, Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment, Carbohydrate Polymers 182 (2018) 42–51.
 Z. Y. Zhang YD, Pan YF, Wang JW, Liu XY, Zhao ZY, Zhang LH, Long B., Study on distribution of liposome nanoparticles loaded quercetin in rats, China medical engineering 15 (2007) 305–308.
 H. Y. Zhang, D. W. Han, Z. F. Zhao, M. S. Liu, Y. J. Wu, X. M. Chen, C. Ji, Multiple pathogenic factor-induced complications of cirrhosis in rats: A new model of hepatopulmonary syndrome with intestinal endotoxemia, World Journal Of Gastroenterology 13 (2007) 3500–3507.
 E. Billerbeck, R. Wolfisberg, U. Fahnoe, J. W. Xiao, C. Quirk, J. M. Luna, J. M. Cullen, A. S. Hartlage, L. Chiriboga, K. Ghoshal, W. I. Lipkin, J. Bukh, T. K. H. Scheel, A. Kapoor, C. M. Rice, Mouse models of acute and chronic hepacivirus infection, Science 357 (2017) 204-+.
 F. J. Cubero, M. E. Zoubek, W. Hu, J. Peng, G. Zhao, Y. A. Nevzorova, M. Al Masaoudi, L. P. Bechmann, M. V. Boekschoten, M. Muller, C. Preisinger, N. Gassler, A. E. Canbay, T. Luedde, R. J. Davis, C. Liedtke, C. Trautwein, Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury, Gastroenterology 150 (2016) 968–981.
 L. Wang, W. Zhang, C. H. Ge, R. H. Yin, Y. Xiao, Y. Q. Zhan, M. Yu, C. Y. Li, Z. Q. Ge, X. M. Yang, Toll-Like Receptor 5 Signaling Restrains T-Cell/Natural Killer T-Cell Activation and Protects Against Concanavalin A-Induced Hepatic Injury, Hepatology 65 (2017) 2059–2073.
 M. W. Wang X, Fang C, Tian S, Zhu X, Yang L, Huang Z, Li H, Dusp14 protects against hepatic ischemia-reperfusion injury via Tak1 suppression., J Hepatol S0168–8278(17)32275–4. (2017).
 T. Nakao, Y. Ono, H. Dai, R. Nakano, A. Perez-Gutierrez, G. Camirand, H. Huang, D. A. Geller, A. W. Thomson, DAP12/TREM2 Expression by Mouse and Human Liver DC: Functional Implications and Regulation of Liver Ischemia-Reperfusion Injury, Hepatology (2018).
 H. Qiao, Y. Zhou, X. Qin, J. Cheng, Y. He, Y. Jiang, NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation, Stem Cells Int 2018 (2018) 1239143.
 F. F. Jia, Z. R. Tan, H. L. McLeod, Y. Chen, D. S. Ou-Yang, H. H. Zhou, Effects of quercetin on pharmacokinetics of cefprozil in Chinese-Han male volunteers, Xenobiotica 46 (2016) 896–900.
 V. Tzankova, D. Aluani, M. Kondeva-Burdina, Y. Yordanov, F. Odzhakov, A. Apostolov, K. Yoncheva, Hepatoprotective and antioxidant activity of quercetin loaded chitosan/alginate particles in vitro and in vivo in a model of paracetamol-induced toxicity, Biomedicine & Pharmacotherapy 92 (2017) 569–579.
 F. Y. Chen, L. F. Cao, H. X. Wan, M. Y. Zhang, J. Y. Cai, L. J. Shen, J. H. Zhong, H. Zhong, Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells, Molecular Medicine Reports 11 (2015) 341–348.
 C. Daglioglu, Enhancing Tumor Cell Response to Multidrug Resistance with pH-Sensitive Quercetin and Doxorubicin Conjugated Multifunctional Nanoparticles, Colloids And Surfaces B-Biointerfaces 156 (2017) 175–185.
 X. Li, Q. W. Jin, Q. Y. Yao, B. L. Xu, L. X. Li, S. C. Zhang, C. T. Tu, The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice, Frontiers In Pharmacology 9 (2018).
 L. W. Wu, Q. H. Zhang, W. H. Mo, J. Feng, S. N. Li, J. J. Li, T. Liu, S. Z. Xu, W. W. Wang, X. Y. Lu, Q. Yu, K. Chen, Y. J. Xia, J. Lu, L. Xu, Y. Q. Zhou, X. M. Fan, C. Y. Guo, Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-beta 1/Smads and PI3K/Akt pathways, Scientific Reports 7 (2017).
 J. Varshosaz, A. Jafarian, G. Salehi, B. Zolfaghari, Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma, Journal Of Liposome Research 24 (2014) 191–203.
 O. Karimi-Khouzani, E. Heidarian, S. A. Amini, Anti-inflammatory and ameliorative effects of gallic acid on fluoxetine-induced oxidative stress and liver damage in rats, Pharmacological Reports 69 (2017) 830–835.